51 results
DEFA14A
AMTI
Applied Molecular Transport Inc.
15 Dec 23
Additional proxy soliciting materials
4:06pm
reimbursement paid by Cyclo to MTS. MTS made AMTI management and the AMTI Board aware of this engagement during the introductory call with AMTI and MTS
8-K
AMTI
Applied Molecular Transport Inc.
15 Dec 23
Other Events
4:05pm
or expense reimbursement paid by Cyclo to MTS. MTS made AMTI management and the AMTI Board aware of this engagement during the introductory call
DEFM14A
AMTI
Applied Molecular Transport Inc.
21 Nov 23
Proxy related to merger
9:16am
Exchange Ratio could be materially different than currently anticipated.
Failure to complete the Merger may result in Cyclo or AMTI paying reimbursement … specified circumstances, AMTI will be required to pay Cyclo a termination fee of $600,000 or the reimbursement of expenses up to $400,000
425
AMTI
Applied Molecular Transport Inc.
21 Sep 23
Business combination disclosure
5:12pm
9.03
Company PSUs
Section 9.03
Company Reimbursement Payment
Section 6.06(c)
Company RSUs
Section 9.03
Company SEC Documents
Section 3.07(a)
Company … Reimbursement Payment
Section 6.06(e)
Parent SEC Documents
Section 4.08(a)
Parent SEC Reports
Section 9.03
Parent Stock Plans
Section 9.03
Parent
8-K
EX-2.1
ki89v6mgh
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
5:10pm
8-K
832b7gtdx8i3c
18 May 22
Applied Molecular Transport Provides Strategy Update
8:18am
S-8
z9t1qzp
4 Mar 22
Registration of securities for employees
6:35am
8-K
EX-10.1
xdx4e5pkmx4f9o
4 Mar 22
Departure of Directors or Certain Officers
6:06am
8-K
EX-10.1
ljh4d3
27 Jan 22
Applied Molecular Transport Announces Board Appointments
5:09pm